Waterbury R&D Tax Credit Explained for Businesses

R&D Tax Credits for Waterbury, Connecticut Businesses

Waterbury, Connecticut, is known for its strong presence in healthcare, manufacturing, education, and retail. Top companies in the city include Waterbury Hospital, a major healthcare provider; Saint Mary’s Hospital, a prominent healthcare provider; Post University, a key educational institution; Timex Group, a leading watch manufacturer; and Walmart, a global retail giant. The R&D Tax Credit can help these industries reduce tax liabilities, encourage innovation, and enhance business performance. By utilizing the R&D Tax Credit, companies can reinvest savings into advanced research, employee training, and operational efficiencies, driving growth and competitiveness in Waterbury’s economy.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 1000 Lafayette Boulevard, Bridgeport, Connecticut is less than 30 miles away from Waterbury and provides R&D tax credit consulting and advisory services to Waterbury and the surrounding areas such as: Bridgeport, New Haven, Stamford, Hartford, and Norwalk.

If you have any questions or need further assistance, please call or email our local Connecticut Partner on (203) 680-9655.
Feel free to book a quick teleconference with one of our Connecticut R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Waterbury, Connecticut Patent of the Year – 2024/2025

Kuprion Inc. has been awarded the 2024/2025 Patent of the Year for its breakthrough in biofilm-resistant surface technology. Their invention, detailed in U.S. Patent Application No. 20240156102, titled ‘Biofilm-resistant articles coated with metal nanoparticle agglomerates’, uses coatings of metal nanoparticle agglomerates to inhibit biofilm formation on surfaces exposed to liquids.

Biofilms are persistent microbial layers that can compromise medical devices, water systems, and industrial equipment. Kuprion’s innovation introduces a coating composed of copper and silver nanoparticles, which disrupts biofilm development. These nanoparticles, ranging from 50 to 250 nanometers, cluster into agglomerates measuring 1 to 35 microns. When applied to surfaces, they create a hostile environment for microbial growth, effectively reducing biofilm formation.

The coating is versatile, suitable for medical implants, water filtration systems, and marine equipment. Its composition includes biologically compatible adhesives, ensuring safety for medical applications. The nanoparticle agglomerates can also incorporate additional compounds like nickel oxide and titanium dioxide to enhance antimicrobial properties.

This development offers a proactive approach to preventing biofilm-related issues, reducing the need for chemical cleaners and extending the lifespan of various devices. By integrating this technology, industries can achieve better hygiene standards and operational efficiency.

Kuprion’s advancement in nanoparticle coatings represents a significant step forward in materials science, providing a practical solution to a widespread problem.